Covered recipient · General Payments record
HINA TAREEN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,184.17
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $681.98 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $198.18 | 11 |
| Amgen Inc. | $155.41 | 7 |
| ANI Pharmaceuticals, Inc. | $154.65 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.14 | 3 |
| UCB, Inc. | $27.87 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.40 | 1 |
| Acerta Pharma LLC | $20.00 | 1 |
| Aurinia Pharma U.S., Inc. | $17.40 | 1 |
| PFIZER INC. | $17.32 | 1 |
| Lilly USA, LLC | $15.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.01 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202488 | CMS |
| ABBVIE INC. | $2.26 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202490 | CMS |
| ABBVIE INC. | $22.59 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202492 | CMS |
| ABBVIE INC. | $19.38 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202494 | CMS |
| ABBVIE INC. | $18.12 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202496 | CMS |
| ABBVIE INC. | $5.73 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202498 | CMS |
| ABBVIE INC. | $18.49 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202500 | CMS |
| ABBVIE INC. | $30.39 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202502 | CMS |
| ABBVIE INC. | $6.82 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202504 | CMS |
| ABBVIE INC. | $24.54 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202506 | CMS |
| ABBVIE INC. | $17.85 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106202508 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.40 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093895138 | CMS |
| Amgen Inc. | $25.75 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111721899 | CMS |
| Amgen Inc. | $31.44 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117396188 | CMS |
| Amgen Inc. | $22.90 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111721901 | CMS |
| Amgen Inc. | $8.65 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117396190 | CMS |
| Amgen Inc. | $29.52 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111721903 | CMS |
| Amgen Inc. | $12.94 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111721895 | CMS |
| Amgen Inc. | $24.21 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111721897 | CMS |
| ANI Pharmaceuticals, Inc. | $129.63 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091159938 | CMS |
| ANI Pharmaceuticals, Inc. | $25.02 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091160040 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.00 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104382447 | CMS |
| Aurinia Pharma U.S., Inc. | $17.40 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150693245 | CMS |
| Lilly USA, LLC | $15.61 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135026194 | CMS |
| Novartis Pharmaceuticals Corporation | $13.41 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087438534 | CMS |
| Novartis Pharmaceuticals Corporation | $20.08 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087438542 | CMS |
| Novartis Pharmaceuticals Corporation | $20.65 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087438546 | CMS |
| PFIZER INC. | $17.32 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130890433 | CMS |
| UCB, Inc. | $27.87 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143162756 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.